{"id":"W4413938704","doi":"10.1007/s40257-025-00975-3","title":"Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Toronto; Probity Medical Research; SKiN Health; University of Calgary","funders":"AbbVie","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Pharmacotherapy; Dermatology; Clinical trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002667724,0.001141575,0.002399256,0.0002916853,0.000537921,0.00118554,0.000857309,0.001439209,0.007273305],"category_scores_gemma":[0.001755312,0.0005170233,0.002508385,0.0004365911,0.0006779107,0.001105553,0.0003938694,0.00297692,0.001029888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007540718,"about_ca_system_score_gemma":0.001537299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005211738,"about_ca_topic_score_gemma":0.00194136,"domain_scores_codex":[0.9992619,0.0003273286,0.00005489656,0.0001381096,0.00007914111,0.0001385851],"domain_scores_gemma":[0.9989737,0.0002014379,0.0002680862,0.0001002619,0.0001061786,0.0003503518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9437095,0.01316689,0.001781522,0.0009947692,0.001925989,0.0000690659,0.00007593997,0.0004622187,0.004692439,0.0001401054,0.002841304,0.03014036],"study_design_scores_gemma":[0.9048547,0.08498279,0.005928937,0.00007553394,0.001087467,0.0001171815,0.00002716493,0.0005268686,0.0007197544,0.0002626737,0.001392254,0.0000246226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9708447,0.008305381,0.001195004,0.0009816587,0.0003975841,0.00996571,0.003337896,0.0002819729,0.004690079],"genre_scores_gemma":[0.9779779,0.003088304,0.002037486,0.001708269,0.0002885709,0.009424672,0.002373231,0.00004124323,0.003060366],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007273305,"threshold_uncertainty_score":0.02433169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02776815026807483,"score_gpt":0.4017457693328107,"score_spread":0.3739776190647359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}